Another No For Vertex As Scotland Rejects Offer For Orkambi And Symkevi

The Scottish Medicines Consortium has issues over the price Vertex Pharmaceuticals is asking for its cystic fibrosis drugs, and like NICE in England it has rejected the products for use on the National Health Service.  

Macro photo of tooth wheel mechanism with FUNDING concept words
Scotland has recommended against funding for two CF drugs. • Source: Shutterstock

More from United Kingdom

More from Europe